Lenient versus Strict Rate Control in Patients with Atrial Fibrillation
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Rate control is often the therapy of choice for atrial fibrillation. Guidelines recommend strict rate control, but this is not based on clinical evidence. We hypothesized that lenient rate control is not inferior to strict rate control for preventing cardiovascular morbidity and mortality in patients with permanent atrial fibrillation. METHODS: We randomly assigned 614 patients with permanent atrial fibrillation to undergo a lenient rate-control strategy (resting heart rate <110 beats per minute) or a strict rate-control strategy (resting heart rate <80 beats per minute and heart rate during moderate exercise <110 beats per minute). The primary outcome was a composite of death from cardiovascular causes, hospitalization for heart failure, and stroke, systemic embolism, bleeding, and life-threatening arrhythmic events. The duration of follow-up was at least 2 years, with a maximum of 3 years. RESULTS: The estimated cumulative incidence of the primary outcome at 3 years was 12.9% in the lenient-control group and 14.9% in the strict-control group, with an absolute difference with respect to the lenient-control group of -2.0 percentage points (90% confidence interval, -7.6 to 3.5; P<0.001 for the prespecified noninferiority margin). The frequencies of the components of the primary outcome were similar in the two groups. More patients in the lenient-control group met the heart-rate target or targets (304 [97.7%], vs. 203 [67.0%] in the strict-control group; P<0.001) with fewer total visits (75 [median, 0], vs. 684 [median, 2]; P<0.001). The frequencies of symptoms and adverse events were similar in the two groups. CONCLUSIONS: In patients with permanent atrial fibrillation, lenient rate control is as effective as strict rate control and is easier to achieve. (ClinicalTrials.gov number, NCT00392613.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There was no difference in a composite of clinical events (14.9% in the strict rate control group, 12.9% in the lenient group), 560 NYHA class, or hospitalizations.560, 561”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [560]
Citations
Cites
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Self-citationVan Gelder, I. C., Hagens, V. E., Bosker, H. A., Kingma, J. H., Kamp, O., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,359
Self-citationEffect of Dronedarone on Cardiovascular Events in Atrial Fibrillation
Hohnloser, S. H., Crijns, H. J. G. M., van Eickels, M., Gaudin, C., Page, R. L., Torp-Pedersen, C., & Connolly, S. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803778 · Cited by 1,129
Self-citationAtrial Fibrillation and Heart Failure: Treatment Considerations for a Dual Epidemic
Anter, E., Jessup, M., & Callans, D. J. (2009) · Circulation · doi:10.1161/circulationaha.108.821306 · Cited by 678
Lechat, P., Hulot, J.-S., Escolano, S., Mallet, A., Leizorovicz, A., Werhlen-Grandjean, M., Pochmalicki, G., & Dargie, H. (2001) · Circulation · doi:10.1161/01.cir.103.10.1428 · Cited by 525
Nerheim, P., Birger-Botkin, S., Piracha, L., & Olshansky, B. (2004) · Circulation · doi:10.1161/01.cir.0000135472.28234.cc · Cited by 378
Van Gelder, I. C., Crijns, H. J. G. M., Blanksma, P. K., Landsman, M. L. J., Posma, J. L., Van Den Berg, M. P., Meijler, F. L., & Lie, K. I. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90352-d · Cited by 269
Self-citationConnolly, S. J., Crijns, H. J. G. M., Torp-Pedersen, C., van Eickels, M., Gaudin, C., Page, R. L., & Hohnloser, S. H. (2009) · Circulation · doi:10.1161/circulationaha.109.875252 · Cited by 261
Self-citation
Cited by
Items 501–600 of 999
Emergency Management of Palpitations in the Elderly
Jamshed, N., Dubin, J. S., & ELDADAH, Z. A. (2012) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2012.10.003 · Cited by 7
Goralnick, E., & Bontempo, L. J. (2015) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2015.04.008 · Cited by 6
Behandlung von Vorhofflimmern in der Intensiv- und Notfallmedizin
Arrigo, M., Béttex, D., & Rudiger, A. (2015) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-015-0006-2 · Cited by 8
Heart failure and atrial fibrillation: Can we break this nexus?
Chugh, S. S. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.11.043 · Cited by 6
Willems, S., Wegner, F. K., & Eckardt, L. (2025) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2025.0082 · Cited by 6
Actualización en cardiología geriátrica
Dı́az-Castro, Ó., López‐Palop, R., Datino, T., & Martínez‐Sellés, M. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.10.035 · Cited by 5
Treatment of Arrhythmias During Pregnancy
Pacheco, L. D., Eyada, M., & Saade, G. R. (2022) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000747 · Cited by 5
Bekiaridou, Α., Samaras, A., Κάρτας, Α., Papazoglou, Α. S., Moysidis, D. V., Patsiou, V., Zafeiropoulos, S., Ziakas, A., Giannakoulas, G. A., & Tzikas, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195843 · Cited by 5
“In patients with AF, coronary artery disease (CAD) coexists at a rate of 13% to 18% in large trials [2,3].”
BackgroundAhluwalia, N., Koehler, J. L., Sarkar, S., Vasudevan, N., Majumder, S., Landman, S. R., & SCHILLING, R. J. (2024) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.124.012842 · Cited by 6
“40,41 The AF event burden was also analyzed in the 10 days immediately after the HF event.”
Management of Patients with Atrial Fibrillation: Specific Considerations for the Old Age
Haegeli, L. M., & Duru, F. (2011) · Cardiology Research and Practice · doi:10.4061/2011/854205 · Cited by 4
Ding, W. Y., Boriani, G., Marín, F. R., Blomström‐Lundqvist, C., Potpara, T., Fauchier, L., Lip, G. Y. H., ESC–EHRA EORP AF Long-Term General Registry Investigators, Boriani, G., Lip, G. Y. H., et al. (2021) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvab076 · Cited by 6
Self-citationArdaya, R., Pratita, J., Juliafina, N. N., Rahman, F. H. F., & Leonardo, K. (2022) · F1000Research · doi:10.12688/f1000research.121598.1 · Cited by 5
“In the RACE (Rate Control Efficacy in Permanent Atrial Fibrillation) II trial, patients set to a stricter limit [heart rate < 80 beats per minute (bpm)] were not associated with lower morbidity, mortality, and hospitalisation when compared to the more lenient group (heart rate <110 bpm).(46) In postoperative AF, both…”
BackgroundGonçalves-Teixeira, P., Costa, T., Fragoso, I., Ferreira, D., Brandao, M., Leite-Moreira, A. F., Sampaio, F., Ribeiro, J., & Fontes‐Carvalho, R. (2022) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201362 · Cited by 9
Use of Diltiazem in Chronic Rate Control for Atrial Fibrillation: A Prospective Case-Control Study
Diemberger, I., Spadotto, A., Massaro, G., Amadori, M., Damaschin, L., Martignani, C., Ziacchi, M., Biffi, M., Galiè, N., & Boriani, G. (2022) · Biology · doi:10.3390/biology12010022 · Cited by 5
“Notably, previous trials such as the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study [13,18] and the Rate Control Efficacy in Permanent Atrial Fibrillation: a Comparison between Lenient versus Strict Rate Control II (RACE II) trial [19] reported a combination of BB and NDCC in 7% and 2.”
MethodCaldarola, P., Iaco, F. D., Pugliese, F. R., Luca, L. D., Fabbri, A., Riccio, C., Scicchitano, P., Vanni, S., Pasquale, G. D., Gulizia, M. M., et al. (2023) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suad110 · Cited by 5
Recent advances in management of atrial fibrillation in patients with heart failure
Shantsila, E., & Lip, G. Y. H. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32835bd465 · Cited by 6
“In a separate study of 614 patients with permanent atrial fibrillation randomized to a strict rate control strategy (as in the clinical trials above) or a lenient rate control strategy (resting heart rate <110 beats/min), no difference was seen in the composite outcome of cardiovascular death, hospitalization for HF,…”
Tratamiento agudo de la fibrilación auricular en urgencias
Martín, A. (2013) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(13)70054-2 · Cited by 6
Almanac 2013: cardiac arrhythmias and pacing
Liew, R. (2013) · Heart · doi:10.1136/heartjnl-2013-304592 · Cited by 8
Özkurt, Y., Özpelit, E., Aslan, Ö., & Göldeli, Ö. (2014) · Kardiologia Polska · doi:10.5603/kp.a2014.0092 · Cited by 5
“8% in the whole study population in RACE II [6].”
BackgroundResultInfluentialBarywani, S. B., & Petzold, M. (2017) · Scandinavian Cardiovascular Journal · doi:10.1080/14017431.2017.1314549 · Cited by 6
“In another study, by Gelder and coworkers, lenient rate control was not inferior to strict rate control [18], but patients with HF included in each arm were only about 9%.”
BackgroundWu, V. C., Otani, K., Yang, C., Chu, P., & Takeuchi, M. (2019) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2018.12.004 · Cited by 5
Rhythm Control of Atrial Fibrillation in Heart Failure with Reduced Ejection Fraction
Burkman, G. M., & Naccarelli, G. V. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01336-8 · Cited by 5
Zyśko, D., Persson, A., Obremska, M., Leśkiewicz, M., Fedorowski, A., Sutton, R., & Johnson, L. (2021) · Kardiologia Polska · doi:10.33963/kp.15820 · Cited by 5
Chourdakis, E., Koniari, I. C., Velissaris, D., Tsigkas, G., Kounis, N., & Osman, N. (2021) · PubMed Central · doi:10.11909/j.issn.1671-5411.2021.05.008 · Cited by 8
“An intensive heart rate control was proven difficult in patients with chronic AF and HFrEF due to patient intolerance of increasing doses of betablockade, and it was not associated with improved outcomes.([110]) Similarly to the study by van Gelder and colleagues, an aggressive rate control in patients with chronic AF…”
ResultVarma, N., Cygankiewicz, I., & Turakhia, M. P. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4420 · Cited by 7
Scarsoglio, S., & Ridolfi, L. (2021) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2204150 · Cited by 5
“Although lenient (resting HR < 110 bpm) and strict (resting HR < 80 bpm) rate control strategies were found not to differ in terms of mid-term cardiovascular outcomes [37], definitive data are still missing [38] and specific findings related to coronary flow impairment are overall scarce.”
BackgroundHunter, T. J., Joseph, J. J., Anazodo, U., Kharche, S., McIntyre, C. W., & Goldman, D. (2022) · Applied Sciences · doi:10.3390/app12031750 · Cited by 5
“[12] are in contrast to the common practice of lenient rate control (<110 bpm), which is based on findings from the RACE II trial, a large, randomized control trial [13].”
MethodResultWhat is the Best Agent for Rate Control of Atrial Fibrillation With Rapid Ventricular Response?
Long, B., Keim, S. M., Gottlieb, M. A., & Stiell, I. G. (2022) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2022.07.014 · Cited by 6
Ray, L., Geier, C., & DeWitt, K. M. (2023) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxad108 · Cited by 6
Nicklas, J. M., Bleske, B. E., Harrison, R. V., Hogikyan, R. V., Kwok, Y. S., & Chavey, W. E. (2013) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2012.11.010 · Cited by 6
“Although strict rate control (<80 bpm at rest and <110 bpm with exercise) yielded equivalent outcomes to rhythm control, recent data in patients with normal systolic function suggest that lenient resting rate control (<110 bpm at rest) may provide equivalent or even superior benefit.(106,107) It is not known if these…”
Management of atrial fibrillation in the acute setting
Chenoweth, J., & Diercks, D. B. (2012) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e328354dc30 · Cited by 7
Antiarrhythmic drugs for atrial fibrillation
Marinelli, A., & Capucci, A. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.554400 · Cited by 6
“A recent trial on the optimal level of heart rate control did not identify a benefit of strict over lenient rate control [99].”
BackgroundTreatment Considerations for a Dual Epidemic of Atrial Fibrillation and Heart Failure.
Sharma, P. S., & Callans, D. J. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.740 · Cited by 6
Iguchi, M., Hamatani, Y., Sugiyama, H., Ishigami, K., Aono, Y., Ikeda, S., Doi, K., Fujino, A., An, Y., Ishii, M., et al. (2020) · Circulation Journal · doi:10.1253/circj.cj-20-0567 · Cited by 5
Interventional Management of Atrial Fibrillation in the Chronic Heart Failure Population
Patel, P. J., & Ahmed, A. S. (2023) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2026.03.001 · Cited by 5
Wang, Y., Yuan, Q.-H., Yuan, J., Du, Z., Zhuang, X.-D., & Liao, X. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-04349-1 · Cited by 6
“Some studies have shown that RHR has no effect on outcomes in AF [32], while lenient rate con-trol has been found to be as effective as strict rate con-trol in patients with permanent AF [27, 33].”
Cavotricuspid Isthmus-Dependent Atrial Flutter. Beyond Simple Linear Ablation
Lizarraga, J. A., Quesada-Ocete, J., Quesada-Ocete, B., Jiménez-Bello, J., & Quesada, A. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2501011 · Cited by 9
“Heart rate goals for patients with atrial flutter have been extrapolated from atrial fibrillation studies, with a rate inferior to 110 beats per minute as a therapeutic goal [ 61].”
BackgroundDiastolic Dysfunction and Atrial Fibrillation: Recognition, Interplay, and Management
Hadid, S. A., Hajj, M. E., Hadid, B., Siddiqui, Z., Wang, A. Y.-Y., Frishman, W. H., & Aronow, W. S. (2024) · Cardiology in Review · doi:10.1097/crd.0000000000000724 · Cited by 4
Okutucu, S., & Görenek, B. (2021) · Cardiology · doi:10.1159/000519465 · Cited by 6
Pharmacologic Rate versus Rhythm Control for Atrial Fibrillation in Heart Failure Patients
Koniari, I. C., Artopoulou, E., Velissaris, D., Mplani, V., Anastasopoulou, M., Kounis, N. G., GREGORIO, C. D., Tsigkas, G., Karunakaran, A., Plotas, P., et al. (2022) · Medicina · doi:10.3390/medicina58060743 · Cited by 6
“Study [Supporting Reference] Rate Control Intervention Rhythm Control Intervention Result of the Study STAF [61] b-blockers digitalis calcium channel blockers Class I agents sotalol b-blocker and/or amiodarone in clinical indication - no difference in the primary and secondary end points between the two treatment stra…”
BackgroundResultInfluentialNessler, J., Krawczyk, K., Leszek, P., Rubiś, P., Rozentryt, P., Gackowski, A., Pawlak, A., Straburzyńska‐Migaj, E., Jankowska, E. A., Brzęk, A., et al. (2023) · Kardiologia Polska · doi:10.33963/kp.a2023.0163 · Cited by 8
Longitudinal Association Between Resting Heart Rate and Mortality in Atrial Fibrillation
Han, K., Li, X., Fu, B., Li, M., Liu, T., Jiang, C., Tang, R., Dong, J., Long, D., & Ma, C. (2024) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2024.10.012 · Cited by 5
van Deutekom, C., Velt, M. J. H., Gelder, I. C. V., Rienstra, M., & Mulder, B. A. (2025) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2025.101686 · Cited by 11
“The RACE II study has been described previously [10].”
Reviewing the use of antiarrhythmic drugs in elderly patients with atrial fibrillation
Menichelli, D., Gazzaniga, G., Malatesta, D., Carlo, G. D., Brogi, T., Pani, A., Pignatelli, P., & Pastori, D. (2025) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2025.2561717 · Cited by 4
“…614 AF patients, showed that a lenient rate strategy ( 110 bpm) was non-inferior to strict rate strategy ( 80 bpm) in preventing cardiovascular death, hospitalization for heart failure, stroke, systemic embolism, bleeding, and life-threating arrhythmic events and was easier to achieve [24].”
Current Approaches to Antiarrhythmic Therapy in Heart Failure
Rose‐Jones, L. J., Bode, W. D., & Gehi, A. K. (2014) · Heart Failure Clinics · doi:10.1016/j.hfc.2014.07.010 · Cited by 6
Atrial fibrillation management: evaluating rate vs rhythm control
Nguyen, T. L., Jolly, U. S., Sidhu, K., Yee, R. K., & Leong‐Sit, P. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2016.1164033 · Cited by 7
“The RACE II Trial compared lenient rate control (resting rate <110 bpm on ECG) versus strict rate control (resting rate <80 bpm and <110 bpm with moderate exercise) and found the more lenient target to be non-inferior for the primary outcome [29].”
MethodAtrial Fibrillation in the Elderly: Management Strategies to Achieve Performance Measures
Wung, S. (2014) · AACN Advanced Critical Care · doi:10.1097/nci.0000000000000027 · Cited by 4
Management Of Atrial Fibrillation In Patients With Heart Failure.
Md, A. E. D. (2014) · PubMed Central · doi:10.4022/jafib.1105 · Cited by 6
Ma, G., Fang, Q., & Wang, F. (2018) · Cardiology Journal · doi:10.5603/cj.a2018.0074 · Cited by 6
“In Rate Control Efficacy in Permanent Atrial Fibrillation: A Comparison between Lenient versus Strict Rate Control II (RACE II) trial, lenient rate control (< 110 bpm) did not yield worse outcomes than strict rate control (< 80 bpm) overall or in the subgroup of patients with HF [28, 29].”
BackgroundDischarge heart rate and 1-year clinical outcomes in heart failure patients with atrial fibrillation
Xing, F., Zheng, X., Zhang, L., Hu, S., Bai, X., Hu, D., Li, B., & Li, J. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001768 · Cited by 5
“Compared with patients with moderate discharge heart rate, those with lower or higher discharge heart rate were more likely to have higher NT-proBNP or lower LVEF.”
BackgroundMethodInfluentialManagement of atrial fibrillation and anticoagulant therapies
O'Neill, M. D., Whitaker, J., Birns, J., & Wright, M. J. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198701590.003.0103 · Cited by 4
Development of a Care Pathway for Atrial Fibrillation Patients in the Emergency Department
Do, D. H., Bernardes‐Souza, B., Merjanian, M., Lombardo, B., Donaldson, D. M., McCullough, L. B., Boyle, N. G., & Cooper, R. J. (2022) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/hpc.0000000000000289 · Cited by 4
Lambiase, P. D., & Maclean, E. (2023) · Heart · doi:10.1136/heartjnl-2022-322122 · Cited by 7
“Furthermore, status, with the exception of proven tachycardiomyopathy[22].”
Atrioventricular Conduction in Atrial Fibrillation: Pathophysiology and Clinical Implications
Róka, A. (2012) · InTech eBooks · doi:10.5772/25417 · Cited by 7
“The frequencies of symptoms and adverse events were similar in the two groups (van Gelder et al., 2010).”
BackgroundBeta-blockers treatment in heart failure with atrial fibrillation — Who should we believe?
Chen, Y., Huang, W., Huang, Y., & Hu, Y. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.096 · Cited by 4
“Data had showed that lenient rate control had similar outcomes with strict rate control in AF patients [12].”
ResultWatanabe, E., Arakawa, T., Okuda, K., Yamamoto, M., Ichikawa, T., Harigaya, H., Sobue, Y., & Ozaki, Y. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.01.022 · Cited by 4
Jacobshagen, C., Westermann, D., Holubarsch, C., & Böhm, M. (2010) · Clinical Research in Cardiology · doi:10.1007/s00392-010-0154-6 · Cited by 5
“Kaplan–Meier estimates of the cumulative incidence of the primary outcome, according to treatment group [12].”
BackgroundAnguita, M. P., Worner, F., Domenech, P., Marín, F. R., Ortigosa, J., Pérez‐Villacastín, J., Fernández‐Ortíz, A., Alonso, Á., Cequier, A. R., Colet, J. C., et al. (2011) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2011.10.005 · Cited by 4
Steinberg, B. A., Beckley, P. D., Deering, T. F., Clark, C. L., Amin, A., Bauer, K. A., Cryer, B., MANSOUR, M. C., Scheiman, J. M., Zenati, M. A., et al. (2013) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/hpc.0b013e31829834ed · Cited by 5
Cost considerations in the management of atrial fibrillation – impact of dronedarone
Khaykin, Y., & Shamiss (2012) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s16675 · Cited by 5
“The concept of what rate qualifies as adequate has seen some changes recently as the investigators of the RACE II trial reported little difference between aggressive rate control targeting a resting rate of 80 beats per minute (bpm) and the more lenient approach aiming at 110 bpm.(18) Most patients in either arm of th…”
Atrial fibrillation: Pathophysiology and current therapy
Miyazaki, S., Shah, A. J., Scherr, D., & Haïssaguerre, M. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.554426 · Cited by 5
“However, a recent trial did not identify a benefi t of stringent rate control over lenient rate control therapy, which targeted a resting heart rate 110 bpm in AF (52).”
BackgroundVezzosi, T., Domenech, O., Cipollini, C., Cantile, C., Côté, É., & Tognetti, R. (2019) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.255.11.1234 · Cited by 4
Evaluación de la fibrilación auricular mediante electrocardiograma y Holter
Mora-Pabón, G. (2016) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2016.10.006 · Cited by 8
Arrhythmias and cardiomyopathy
Bonadei, I., Gorga, E., Lombardi, C., & Metra, M. (2016) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000464 · Cited by 5
Cardiac fibrillation—challenges and evolving solutions
Nattel, S. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.133 · Cited by 4
Ostrom, L. T., & Wilhelmsen, C. A. (2012) · Wiley eBooks · doi:10.1002/9781118309629.ch3 · Cited by 4
New European guidelines on atrial fibrillation
Hunter, R. J., & Schilling, R. (2011) · BMJ · doi:10.1136/bmj.d897 · Cited by 4
Acute Rate Control in Atrial Fibrillation With Left Ventricular Dysfunction
Momomura, S. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0289 · Cited by 4
Ferrick, K. J. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.04.002 · Cited by 4
Management Strategies in Atrial Fibrillation in Patients With Heart Failure
Shaikh, A. Y., Maan, A., Heist, E. K., Tighe, D. A., Aurigemma, G. P., & McManus, D. D. (2012) · Cardiology in Review · doi:10.1097/crd.0b013e31825dcf9b · Cited by 3
Tseng, A. S., Kowlgi, G. N., & DeSimone, C. V. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.01.010 · Cited by 3
Park, H., Yu, H. T., Kim, T., Park, J., Park, J., Kang, K., Uhm, J., Kim, J., Kim, J., Choi, E., et al. (2023) · International Journal of Arrhythmia · doi:10.1186/s42444-023-00090-6 · Cited by 3
“Although there were reasons to expect improved prognosis under strict rate control, the RACE-II (Rate Control Efficacy in Permanent Atrial Fibrillation: a Comparison between Lenient versus Strict Rate Control II) trial demonstrated no significant difference in cardiovascular outcomes between patients with strict rate…”
BackgroundKim, Y., Ahn, M., Yoo, B., Kim, J., Son, J., Park, Y. J., Kim, S. H., Kang, D. R., Lee, H., Kang, S., et al. (2024) · International Journal of Heart Failure · doi:10.36628/ijhf.2023.0052 · Cited by 4
“The Rate Control Efficacy in Permanent Atrial Fibrillation: a Comparison Between Lenient Versus Strict Rate Control II (RACE II trial) demonstrated a more lenient HR control strategy of up to 100 bpm was not inferior to a strict HR control of <80 bpm with a numerical signal towards a better outcomes at higher HR. 24)…”
BackgroundInfluentialArrhythmien bei Schilddrüsenerkrankungen
Brenner, R., Bilz, S., Busch, S., Rickli, H., Ammann, P., & Maeder, M. T. (2024) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-024-01030-0 · Cited by 3
Wang, J.-Y., Mo, R., Zhu, J., Tan, J., Wang, L., Xu, W., Wang, J., Wu, S., Lyu, S., Zhang, H., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35218 · Cited by 3
“… 110 bpm) or a strict strategy (resting heart rate 80 bpm and heart rate during moderate exercise 110 bpm), rate-control therapy could prevent the composite outcome of cardiovascular death, heart failure hospitalization, stroke, systemic embolism, bleeding, and life threatening arrhythmic [21].”
BackgroundPrevention of New-Onset Heart Failure in Atrial Fibrillation: The Role of Pharmacological Management
Zobdeh, A., Hoyle, D. J., Shastri, P., Bezabhe, W. M. M., & Peterson, G. M. (2024) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-024-00703-y · Cited by 3
“Additionally, a comparison of the efficacy of each negative dromo-tropic drug group in controlling the heart rate or the effect on mortality and hospitalization due to heart failure was not reported [32].”
InfluentialAhluwalia, N., Honarbakhsh, S., Joshi, A., Abbass, H., CHOW, A. W. C., Dhinoja, M., Petersen, S. E., Lloyd, G., Hunter, R. J., & SCHILLING, R. J. (2024) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2024.10.020 · Cited by 3
Current approaches in atrial fibrillation treatment
Sarı, C. (2014) · Dicle Medical Journal / Dicle Tip Dergisi · doi:10.5798/diclemedj.0921.2014.03.0487 · Cited by 3
Ablation of Atrial Arrhythmias in Heart Failure
Aagaard, P., Biase, L. D., & Natale, A. (2015) · Heart Failure Clinics · doi:10.1016/j.hfc.2014.12.008 · Cited by 4
Végh, É., Sood, N. A., & Singh, J. P. (2013) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.07.003 · Cited by 3
Liew, R. (2014) · Acta cardiologica. Supplementum · doi:10.1080/ac.69.2.3017312 · Cited by 3
“The RACE (Rate Control Efficacy in Permanent Atrial Fibrillation) II trial was the first formal assessment of alternative rate control goals in AF and demonstrated for the first time that a ‘lenient rate control’ strategy (target resting heart rate < 110 beats/min) was non-inferior to a ‘strict rate control’ strategy…”
Atrial Fibrillation Ablation in Heart Failure Patients
Derndorfer, M., Chen, S., & Pürerfellner, H. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163512 · Cited by 3
Schnabel, R. B., Rillig, A., & Kirchhof, P. F. (2021) · Der Internist · doi:10.1007/s00108-021-01067-0 · Cited by 4
Hesse, K. (2022) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2022.100218 · Cited by 6
Kodani, E., Inoue, H., Atarashi, H., Okumura, K., Yamashita, T., Origasa, H., & J-RHYTHM Registry Investigators (2022) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2022.101148 · Cited by 3
“In addition, even when the cutoff HR values of 80 and 110 bpm, the target HR values in the RACE II trial [4], were adopted for arbitrary baseline HR groups (<60, 60–79, 80–109, and ≥ 110 bpm), these groups also showed no significant trend for any event across the groups (Table 2).”
BackgroundMethodInfluentialIkeda, T., Yamashita, T., Akao, M., Atarashi, H., Koretsune, Y., Okumura, K., Shimizu, W., Suzuki, S. S., Tsutsui, H., Toyoda, Ḱ., et al. (2022) · Journal of Cardiology · doi:10.1016/j.jjcc.2022.11.011 · Cited by 3
Chaumont, C., Omouri, L., Savouré, A., Hamoud, R. A., Fauvel, C., GODIN, B., Eltchaninoff, H., & Anselme, F. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14349 · Cited by 3
Chronic kidney disease and atrial fibrillation: approaches to the choice of antiarrhythmic therapy
Tatarsky, B. A., & Владимировна, К. Н. (2024) · Сибирский журнал клинической и экспериментальной медицины · doi:10.29001/2073-8552-2023-38-4-20-28 · Cited by 3
Martín, A., Calvo, D., Llamas, P., Roldán, V., León, R. C., Almela, A. F. D. S., Ávila, P., del Arco, C., Arbelo, E., Piñera, P., et al. (2024) · Emergencias · doi:10.55633/s3me/e027.2023 · Cited by 3
Kishihara, M., Kawakami, R., Fukushima, N., Abe, T., Takada, T., Shirotani, S., Yoshida, A., Hata, T., Watanabe, S., Kawamoto, T., et al. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.101120 · Cited by 3
Heart failure with preserved ejection fraction and atrial fibrillation
Lenormand, T., Bisson, A., & Fauchier, L. (2025) · Minerva Medica · doi:10.23736/s0026-4806.25.09602-8 · Cited by 4
Atrial Fibrillation in Women: Risks and Management
Prabakaran, S., Nieto, M. C. G., & Lundberg, G. P. (2017) · Journal of Women s Health · doi:10.1089/jwh.2016.6282 · Cited by 5
Vorgehen bei Vorhofflimmern mit tachykarder Überleitung
Hadjamu, N., Azizy, O., & Wakili, R. (2020) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-020-00670-2 · Cited by 3
Frequenz- und Rhythmuskontrolle bei Vorhofflimmern: Medikamentöse Ansätze
Weipert, K. F., Erkapic, D., & Schmitt, J. (2015) · Herz · doi:10.1007/s00059-014-4201-3 · Cited by 6
Heart Failure: Systolic Dysfunction
Koehler, J. M., & Walton, A. M. (2014) · Digital Commons @ Butler University (Butler University) · Cited by 3
Management of atrial fibrillation: What is new in the 2014 ACC/AHA/HRS guideline?
Rajagopalan, B., & Curtis, A. B. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2015.1022495 · Cited by 3
“A single randomized trial (RACE II) showed that a lenient rate control strategy of <110 bpm was noninferior to a strict rate control strategy of <80 bpm [30].”
MethodTherapie des Vorhofflimmern beim kritisch Kranken
Willich, T., Hammwöhner, M., & Goette, A. (2012) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-012-0082-5 · Cited by 4
Amerena, J. V., Chen, S., Sriratanasathavorn, C., Cho, J. G., Dejia, H., Omar, R., Fat, T. H., & King, A. (2011) · Clinical Medicine Insights Cardiology · doi:10.4137/cmc.s6289 · Cited by 3
Impact of Atrial Fibrillation on Outcomes in Heart Failure
DePasquale, E. C., & Fonarow, G. C. (2013) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.07.009 · Cited by 3
Is Catheter Ablation a Mature Fruit for Treatment of Atrial Fibrillation?
Yamashita, T. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0659 · Cited by 4
Metadata
- Authors
- Van Gelder, I. C., Groenveld, H. F., Crijns, H. J. G. M., Tuininga, Y. S., Tijssen, J. G. P., Alings, A. M., Hillege, H. L., Bergsma-Kadijk, J. A., Cornel, J. H., Kamp, O., Tukkie, R., Bosker, H. A., Van Veldhuisen, D. J., & Van den Berg, M. P.
- Affiliations
- University Medical Center Groningen (NL)
- Maastricht University Medical Centre (NL)
- Deventer Ziekenhuis (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Medisch Centrum Alkmaar (NL)
- Rijnstate Hospital (NL)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-04-15
- Volume
- 362
- Issue
- 15
- Pages
- 1363-1373
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2102129403
- Cited by
- 1,033
- References
- 19
- Citations by year
- 2026: 36 · 2025: 55 · 2024: 59 · 2023: 61 · 2022: 56 · 2021: 63 · 2020: 44 · 2019: 50 · 2018: 45 · 2017: 62 · 2016: 56 · 2015: 51 · 2014: 81 · 2013: 94 · 2012: 83
- FWCI
- 68.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- atrial fibrillation, rate control, resting heart rate, non-inferiority, cardiovascular morbidity and mortality, heart failure hospitalization, stroke, hemorrhage, arrhythmic events, anticoagulation
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Anti-Arrhythmia Agents, Atrial Fibrillation, Calcium Channel Blockers, Female, Follow-Up Studies, Heart Rate, Humans, Male, Middle Aged, Confidence Intervals, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.